Characterization of antiserum against myeloma cells.
D000276:Adjuvants, Immunologic; D000327:Adsorption; D000818:Animals; D000951:Antigens, Neoplasm / Q000032:analysis; D001402:B-Lymphocytes / Q000276:immunology; D001853:Bone Marrow / Q000276:immunology; D001854:Bone Marrow Cells; D002460:Cell Line; D002462:Cell Membrane / Q000276:immunology; D005455:Fluorescent Antibody Technique; D006041:Goats / Q000276:immunology; D006801:Humans; D007106:Immune Sera; D005779:Immunodiffusion; D007070:Immunoglobulin A; D007072:Immunoglobulin D; D007073:Immunoglobulin E; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007938:Leukemia / Q000276:immunology; D008214:Lymphocytes / Q000276:immunology; D009101:Multiple Myeloma / Q000276:immunology*; D010950:Plasma Cells / Q000276:immunology; D011817:Rabbits / Q000276:immunology; D014732:Vibration; D008258:Waldenstrom Macroglobulinemia / Q000276:immunology
D000276:Adjuvants, Immunologic; D000951:Antigens, Neoplasm; D007106:Immune Sera; D007070:Immunoglobulin A; D007072:Immunoglobulin D; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007073:Immunoglobulin E